APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Narcotics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Opioid Narcotics Industry Growth and Trends Forecast to 2032

27 December 2025108 pages

Choose your research edition.

Industry ResearchOpioid Narcotics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Narcotics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Narcotics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Narcotics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Narcotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Opioid Narcotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Opioid Narcotics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Opioid Narcotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Opioid Narcotics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Opioid Narcotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Opioid Narcotics Market by Company

Yichang Renfu Pharmaceutical Co., Ltd.

Jiangsu Enhua Pharmaceutical Co., Ltd.

Henan Lingrui Pharmaceutical Co., Ltd.

Sinopharm Group Industrial Co., Ltd. Langfang Branch

Changzhou Siyao Pharmaceutical Co., Ltd.

Reig Jofre

Pfizer

GSK

Fresenius Kabi

Daiichi Sankyo

AcelRx Pharmaceuticals, Inc

Abbott

Opioid Narcotics Segment by Type

Fentanyl

Remifentanil

Sufentanil

Opioid Narcotics Segment by Application

Hospital

Clinic

Other

Opioid Narcotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fentanyl Table 2. Major Company of Remifentanil Table 3. Major Company of Sufentanil Table 4. Global Opioid Narcotics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 6. Global Opioid Narcotics Sales Market Share in Volume by Type (2021-2026) Table 7. Global Opioid Narcotics Sales by Type (2021-2026) & (US$ Million) Table 8. Global Opioid Narcotics Sales Market Share in Value by Type (2021-2026) Table 9. Global Opioid Narcotics Price by Type (2021-2026) & (US$/Unit) Table 10. Global Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 11. Global Opioid Narcotics Sales Market Share in Volume by Type (2027-2032) Table 12. Global Opioid Narcotics Sales by Type (2027-2032) & (US$ Million) Table 13. Global Opioid Narcotics Sales Market Share in Value by Type (2027-2032) Table 14. Global Opioid Narcotics Price by Type (2027-2032) & (US$/Unit) Table 15. North America Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 16. North America Opioid Narcotics Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 18. Europe Opioid Narcotics Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Opioid Narcotics Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 22. Latin America Opioid Narcotics Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Opioid Narcotics Sales by Type (2021-2026) & (US$ Million) Table 25. Opioid Narcotics Industry Trends Table 26. Opioid Narcotics Industry Drivers Table 27. Opioid Narcotics Industry Opportunities and Challenges Table 28. Opioid Narcotics Industry Restraints Table 29. Global Opioid Narcotics Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Opioid Narcotics Revenue Market Share by Company (2021-2026) Table 31. Global Opioid Narcotics Sales by Company (2021-2026) & (K Units) Table 32. Global Opioid Narcotics Sales Share by Company (2021-2026) Table 33. Global Opioid Narcotics Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Opioid Narcotics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Opioid Narcotics Major Company Production Sites and Headquarters Table 36. Global Opioid Narcotics Company, Product Type & Application Table 37. Global Opioid Narcotics Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Opioid Narcotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Opioid Narcotics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Opioid Narcotics Sales by Region (2021-2026) & (K Units) Table 42. Global Opioid Narcotics Sales Market Share in Volume by Region (2021-2026) Table 43. Global Opioid Narcotics Sales by Region (2021-2026) & (US$ Million) Table 44. Global Opioid Narcotics Sales Market Share in Value by Region (2021-2026) Table 45. Global Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Opioid Narcotics Sales by Region (2027-2032) & (K Units) Table 47. Global Opioid Narcotics Sales Market Share in Volume by Region (2027-2032) Table 48. Global Opioid Narcotics Sales by Region (2027-2032) & (US$ Million) Table 49. Global Opioid Narcotics Sales Market Share in Value by Region (2027-2032) Table 50. Global Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Opioid Narcotics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 53. Global Opioid Narcotics Sales Market Share in Volume by Application (2021-2026) Table 54. Global Opioid Narcotics Sales by Application (2021-2026) & (US$ Million) Table 55. Global Opioid Narcotics Sales Market Share in Value by Application (2021-2026) Table 56. Global Opioid Narcotics Price by Application (2021-2026) & (US$/Unit) Table 57. Global Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 58. Global Opioid Narcotics Sales Market Share in Volume by Application (2027-2032) Table 59. Global Opioid Narcotics Sales by Application (2027-2032) & (US$ Million) Table 60. Global Opioid Narcotics Sales Market Share in Value by Application (2027-2032) Table 61. Global Opioid Narcotics Price by Application (2027-2032) & (US$/Unit) Table 62. North America Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 63. North America Opioid Narcotics Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 65. Europe Opioid Narcotics Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Opioid Narcotics Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 69. Latin America Opioid Narcotics Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Opioid Narcotics Sales by Application (2021-2026) & (US$ Million) Table 72. Yichang Renfu Pharmaceutical Co., Ltd. Company Information Table 73. Yichang Renfu Pharmaceutical Co., Ltd. Business Overview Table 74. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 76. Yichang Renfu Pharmaceutical Co., Ltd. Recent Development Table 77. Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information Table 78. Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview Table 79. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 81. Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Development Table 82. Henan Lingrui Pharmaceutical Co., Ltd. Company Information Table 83. Henan Lingrui Pharmaceutical Co., Ltd. Business Overview Table 84. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 86. Henan Lingrui Pharmaceutical Co., Ltd. Recent Development Table 87. Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information Table 88. Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview Table 89. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio Table 91. Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Development Table 92. Changzhou Siyao Pharmaceutical Co., Ltd. Company Information Table 93. Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview Table 94. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 96. Changzhou Siyao Pharmaceutical Co., Ltd. Recent Development Table 97. Reig Jofre Company Information Table 98. Reig Jofre Business Overview Table 99. Reig Jofre Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Reig Jofre Opioid Narcotics Product Portfolio Table 101. Reig Jofre Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Opioid Narcotics Product Portfolio Table 106. Pfizer Recent Development Table 107. GSK Company Information Table 108. GSK Business Overview Table 109. GSK Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. GSK Opioid Narcotics Product Portfolio Table 111. GSK Recent Development Table 112. Fresenius Kabi Company Information Table 113. Fresenius Kabi Business Overview Table 114. Fresenius Kabi Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Fresenius Kabi Opioid Narcotics Product Portfolio Table 116. Fresenius Kabi Recent Development Table 117. Daiichi Sankyo Company Information Table 118. Daiichi Sankyo Business Overview Table 119. Daiichi Sankyo Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Daiichi Sankyo Opioid Narcotics Product Portfolio Table 121. Daiichi Sankyo Recent Development Table 122. AcelRx Pharmaceuticals, Inc Company Information Table 123. AcelRx Pharmaceuticals, Inc Business Overview Table 124. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio Table 126. AcelRx Pharmaceuticals, Inc Recent Development Table 127. Abbott Company Information Table 128. Abbott Business Overview Table 129. Abbott Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Abbott Opioid Narcotics Product Portfolio Table 131. Abbott Recent Development Table 132. North America Opioid Narcotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. North America Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 134. North America Opioid Narcotics Sales Market Share by Country (2021-2026) Table 135. North America Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units) Table 136. North America Opioid Narcotics Sales Market Share Forecast by Country (2027-2032) Table 137. North America Opioid Narcotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Opioid Narcotics Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Opioid Narcotics Market Share by Country (2021-2026) Table 140. North America Opioid Narcotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Opioid Narcotics Market Share Forecast by Country (2027-2032) Table 142. Europe Opioid Narcotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Europe Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 144. Europe Opioid Narcotics Sales Market Share by Country (2021-2026) Table 145. Europe Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units) Table 146. Europe Opioid Narcotics Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Opioid Narcotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Opioid Narcotics Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Opioid Narcotics Market Share by Country (2021-2026) Table 150. Europe Opioid Narcotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Opioid Narcotics Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Opioid Narcotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 154. Asia-Pacific Opioid Narcotics Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units) Table 156. Asia-Pacific Opioid Narcotics Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Opioid Narcotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Opioid Narcotics Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Opioid Narcotics Market Share by Country (2021-2026) Table 160. Asia-Pacific Opioid Narcotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Opioid Narcotics Market Share Forecast by Country (2027-2032) Table 162. Latin America Opioid Narcotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Latin America Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 164. Latin America Opioid Narcotics Sales Market Share by Country (2021-2026) Table 165. Latin America Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units) Table 166. Latin America Opioid Narcotics Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Opioid Narcotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Opioid Narcotics Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Opioid Narcotics Market Share by Country (2021-2026) Table 170. Latin America Opioid Narcotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Opioid Narcotics Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Opioid Narcotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Opioid Narcotics Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Opioid Narcotics Sales Forecast by Country (2027-2032) & (K Units) Table 176. Middle East and Africa Opioid Narcotics Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Opioid Narcotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Opioid Narcotics Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Opioid Narcotics Market Share by Country (2021-2026) Table 180. Middle East and Africa Opioid Narcotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Opioid Narcotics Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Opioid Narcotics Distributors List Table 185. Opioid Narcotics Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Opioid Narcotics Image Figure 2. Global Opioid Narcotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Narcotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioid Narcotics Sales (2021-2032) & (K Units) Figure 5. Fentanyl Image Figure 6. Global Fentanyl Sales YoY Growth (2021-2032) & (K Units) Figure 7. Remifentanil Image Figure 8. Global Remifentanil Sales YoY Growth (2021-2032) & (K Units) Figure 9. Sufentanil Image Figure 10. Global Sufentanil Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Opioid Narcotics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Opioid Narcotics Market Share by Type 2025 VS 2032 Figure 13. North America Opioid Narcotics Sales Market Share in Volume by Type in 2025 Figure 14. North America Opioid Narcotics Sales Market Share in Value by Type in 2025 Figure 15. Europe Opioid Narcotics Sales Market Share in Volume by Type in 2025 Figure 16. Europe Opioid Narcotics Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Opioid Narcotics Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Opioid Narcotics Sales Market Share in Value by Type in 2025 Figure 19. Latin America Opioid Narcotics Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Opioid Narcotics Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Opioid Narcotics Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Opioid Narcotics Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Opioid Narcotics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Opioid Narcotics Market Share by Application 2025 VS 2032 Figure 33. North America Opioid Narcotics Sales Market Share in Volume by Application in 2025 Figure 34. North America Opioid Narcotics Sales Market Share in Value by Application in 2025 Figure 35. Europe Opioid Narcotics Sales Market Share in Volume by Application in 2025 Figure 36. Europe Opioid Narcotics Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Opioid Narcotics Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Opioid Narcotics Sales Market Share in Value by Application in 2025 Figure 39. Latin America Opioid Narcotics Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Opioid Narcotics Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Opioid Narcotics Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Opioid Narcotics Sales Market Share in Value by Application in 2025 Figure 43. North America Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Opioid Narcotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Opioid Narcotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Opioid Narcotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Opioid Narcotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Opioid Narcotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Opioid Narcotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Opioid Narcotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Opioid Narcotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Opioid Narcotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Opioid Narcotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Opioid Narcotics Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Opioid Narcotics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Remifentanil
  • Sufentanil
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yichang Renfu Pharmaceutical Co., Ltd.
  • Jiangsu Enhua Pharmaceutical Co., Ltd.
  • Henan Lingrui Pharmaceutical Co., Ltd.
  • Sinopharm Group Industrial Co., Ltd. Langfang Branch
  • Changzhou Siyao Pharmaceutical Co., Ltd.
  • Reig Jofre
  • Pfizer
  • GSK
  • Fresenius Kabi
  • Daiichi Sankyo
  • AcelRx Pharmaceuticals, Inc
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Narcotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Opioid Narcotics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Opioid Narcotics Market by Type
  6. 1.3.1 Fentanyl
  7. 1.3.2 Remifentanil
  8. 1.3.3 Sufentanil
  9. 1.4 Global Opioid Narcotics Market Size by Type
  10. 1.4.1 Global Opioid Narcotics Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Opioid Narcotics Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Opioid Narcotics Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Opioid Narcotics Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Opioid Narcotics Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Opioid Narcotics Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Opioid Narcotics Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Opioid Narcotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Opioid Narcotics Industry Trends
  2. 2.2 Opioid Narcotics Industry Drivers
  3. 2.3 Opioid Narcotics Industry Opportunities and Challenges
  4. 2.4 Opioid Narcotics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Opioid Narcotics Revenue (2021-2026)
  2. 3.2 Global Top Players by Opioid Narcotics Sales (2021-2026)
  3. 3.3 Global Top Players by Opioid Narcotics Price (2021-2026)
  4. 3.4 Global Opioid Narcotics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioid Narcotics Major Company Production Sites & Headquarters
  6. 3.6 Global Opioid Narcotics Company, Product Type & Application
  7. 3.7 Global Opioid Narcotics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioid Narcotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioid Narcotics Tier 1, Tier 2, and Tier 3
4 Opioid Narcotics Regional Status and Outlook
  1. 4.1 Global Opioid Narcotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Opioid Narcotics Historic Market Size by Region
  3. 4.2.1 Global Opioid Narcotics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Opioid Narcotics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Opioid Narcotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Opioid Narcotics Forecasted Market Size by Region
  7. 4.3.1 Global Opioid Narcotics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Opioid Narcotics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Opioid Narcotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Opioid Narcotics by Application
  1. 5.1 Opioid Narcotics Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Opioid Narcotics Market Size by Application
  6. 5.2.1 Global Opioid Narcotics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Opioid Narcotics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Opioid Narcotics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Opioid Narcotics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Opioid Narcotics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Opioid Narcotics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Opioid Narcotics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Opioid Narcotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yichang Renfu Pharmaceutical Co., Ltd.
  2. 6.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  6. 6.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
  8. 6.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  12. 6.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Henan Lingrui Pharmaceutical Co., Ltd.
  14. 6.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  18. 6.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
  20. 6.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
  21. 6.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
  22. 6.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
  24. 6.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
  25. 6.5 Changzhou Siyao Pharmaceutical Co., Ltd.
  26. 6.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  30. 6.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Reig Jofre
  32. 6.6.1 Reig Jofre Company Information
  33. 6.6.2 Reig Jofre Business Overview
  34. 6.6.3 Reig Jofre Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Reig Jofre Opioid Narcotics Product Portfolio
  36. 6.6.5 Reig Jofre Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Opioid Narcotics Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Opioid Narcotics Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Fresenius Kabi
  50. 6.9.1 Fresenius Kabi Company Information
  51. 6.9.2 Fresenius Kabi Business Overview
  52. 6.9.3 Fresenius Kabi Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
  54. 6.9.5 Fresenius Kabi Recent Developments
  55. 6.10 Daiichi Sankyo
  56. 6.10.1 Daiichi Sankyo Company Information
  57. 6.10.2 Daiichi Sankyo Business Overview
  58. 6.10.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
  60. 6.10.5 Daiichi Sankyo Recent Developments
  61. 6.11 AcelRx Pharmaceuticals, Inc
  62. 6.11.1 AcelRx Pharmaceuticals, Inc Company Information
  63. 6.11.2 AcelRx Pharmaceuticals, Inc Business Overview
  64. 6.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
  66. 6.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
  67. 6.12 Abbott
  68. 6.12.1 Abbott Company Information
  69. 6.12.2 Abbott Business Overview
  70. 6.12.3 Abbott Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbott Opioid Narcotics Product Portfolio
  72. 6.12.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Opioid Narcotics Sales by Country
  2. 7.1.1 North America Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Opioid Narcotics Sales by Country (2021-2026)
  4. 7.1.3 North America Opioid Narcotics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Opioid Narcotics Market Size by Country
  6. 7.2.1 North America Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Opioid Narcotics Market Size by Country (2021-2026)
  8. 7.2.3 North America Opioid Narcotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Opioid Narcotics Sales by Country
  2. 8.1.1 Europe Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Opioid Narcotics Sales by Country (2021-2026)
  4. 8.1.3 Europe Opioid Narcotics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Opioid Narcotics Market Size by Country
  6. 8.2.1 Europe Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Opioid Narcotics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Opioid Narcotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Opioid Narcotics Sales by Country
  2. 9.1.1 Asia-Pacific Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Opioid Narcotics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Opioid Narcotics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Opioid Narcotics Market Size by Country
  6. 9.2.1 Asia-Pacific Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Opioid Narcotics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Opioid Narcotics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Opioid Narcotics Sales by Country
  2. 10.1.1 South America Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Opioid Narcotics Sales by Country (2021-2026)
  4. 10.1.3 South America Opioid Narcotics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Opioid Narcotics Market Size by Country
  6. 10.2.1 South America Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Opioid Narcotics Market Size by Country (2021-2026)
  8. 10.2.3 South America Opioid Narcotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Opioid Narcotics Sales by Country
  2. 11.1.1 Middle East and Africa Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Opioid Narcotics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Opioid Narcotics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Opioid Narcotics Market Size by Country
  6. 11.2.1 Middle East and Africa Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Opioid Narcotics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Opioid Narcotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Opioid Narcotics Value Chain Analysis
  2. 12.1.1 Opioid Narcotics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Opioid Narcotics Production Mode & Process
  7. 12.2 Opioid Narcotics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Opioid Narcotics Distributors
  10. 12.2.3 Opioid Narcotics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst